These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 20637961

  • 1. Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.
    Christensen T, Buckland A, Bentley A, Djurhuus C, Baker-Searle R.
    Clin Ther; 2010 Jun; 32(6):1068-82. PubMed ID: 20637961
    [Abstract] [Full Text] [Related]

  • 2. The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden.
    Christensen T, Fidler C, Bentley A, Djurhuus C.
    J Med Econ; 2010 Mar; 13(1):168-78. PubMed ID: 20136580
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

  • 4. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ, Boonstra VH, Hokken-Koelega AC.
    Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
    [Abstract] [Full Text] [Related]

  • 5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone treatment for short stature in children born small for gestational age.
    Jung H, Rosilio M, Blum WF, Drop SL.
    Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A, Cooper K, Bird A, Baxter L, Frampton GK, Gospodarevskaya E, Welch K, Bryant J.
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [Abstract] [Full Text] [Related]

  • 9. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, Longás AF.
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [Abstract] [Full Text] [Related]

  • 10. Economic implications of growth hormone use in patients with short bowel syndrome.
    Migliaccio-Walle K, Caro JJ, Möller J.
    Curr Med Res Opin; 2006 Oct; 22(10):2055-63. PubMed ID: 17022865
    [Abstract] [Full Text] [Related]

  • 11. [Growth hormone treatment of short children born small for gestational age].
    Christesen HB, Jensen RB, Birkebaek NH, Hertel NT, Main KM, Mortensen HB, Naeraa RW, Juul A.
    Ugeskr Laeger; 2006 Feb 27; 168(9):889-95. PubMed ID: 16513050
    [Abstract] [Full Text] [Related]

  • 12. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW, Willemsen RH, van der Kaay DC, van Dijk M, Visser TJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Aug 27; 69(2):318-22. PubMed ID: 18221400
    [Abstract] [Full Text] [Related]

  • 13. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
    Simon D, Léger J, Carel JC.
    Best Pract Res Clin Endocrinol Metab; 2008 Jun 27; 22(3):525-37. PubMed ID: 18538291
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
    Lacey LA, Wolf A, O'shea D, Erny S, Ruof J.
    Int J Obes (Lond); 2005 Aug 27; 29(8):975-82. PubMed ID: 15852050
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone treatment strategy for short children born small for gestational age.
    Czernichow P.
    Horm Res; 2004 Aug 27; 62 Suppl 3():137-40. PubMed ID: 15539815
    [Abstract] [Full Text] [Related]

  • 16. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G, Andlin-Sobocki P, Brophy S, Jönsson L, Calin A, Braun J.
    Rheumatology (Oxford); 2004 Sep 27; 43(9):1158-66. PubMed ID: 15226514
    [Abstract] [Full Text] [Related]

  • 17. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W, Bannink E, van Dijk M, Willemsen R, van der Kaay D, de Ridder M, Hokken-Koelega A.
    Horm Res; 2008 Sep 27; 69(2):89-98. PubMed ID: 18059089
    [Abstract] [Full Text] [Related]

  • 18. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW, Willemsen RH, van der Kaay DC, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Jul 27; 71(1):65-73. PubMed ID: 19094073
    [Abstract] [Full Text] [Related]

  • 19. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY, Ko SK, Liew D.
    Clin Ther; 2009 Dec 27; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [Abstract] [Full Text] [Related]

  • 20. Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children.
    Joshi AV, Munro V, Russell MW.
    Curr Med Res Opin; 2006 Feb 27; 22(2):351-7. PubMed ID: 16466607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.